Aspen Medical Products Malaysia Sdn Bhd

Aspen Pharma, is a  multinational pharmaceutical company, with 26 manufacturing facilities at 18 sites on 6 continents with approximately 10,000 employees. We are committed to sustaining life and promoting healthcare through increasing access to its high quality, effective, affordable medicines and products globally. Aspen Pharma has an extensive market presence and is represented in more than 70 countries.

The Aspen Group’s Asia-Pacific presence was extended to include an office in Selangor, where Aspen Malaysia began trading on 1 July 2013. In Malaysia, this business unit’s focus is on marketing existing leading originator brands and extending their sales into the private sector. It’s initial product range included Zyloric, Oroxine, Trandate, Lanoxin, Imuran, Alkeran, Leukeran, Myleran and Lanvis. with ongoing focus and product line extension taking place to meet the needs of the Malaysian citizens. More recently the product range was extended to include Arixtra, an anticoagulant indicated for cardiology and orthopedic treatments thereby enhancing Aspen Malaysia’s therapeutic basket which presently comprises cardiovascular, endocrine and metabolic, immunosuppressant and oncology therapeutic products.

 

 

At Aspen Malaysia, we believe tried and trusted brands in medicine are like treasures: